Kilonda; Amuri

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kilonda; Amuri.The latest application filed is for "compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders".

Company Profile

4.11.13

Kilonda; Amuri - Boutersem BE
Kilonda; Amuri - Roosbeek-Boutersem BE
Kilonda; Amuri - Leuven BE
- Roosbeek-Boutersem BE
Kilonda; Amuri - Heverlee BE
Kilonda; Amuri - Kessel-Lo BE
Kilonda; Amuri - City Heverlee BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For The Treatment Of Epilepsy, Neurodegenerative Disorders And Other Cns Disorders App 20200095238 - Griffioen; Johan Gerard ; et al.	2020-03-26
Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases App 20190054068 - Griffioen; Gerard ; et al.	2019-02-21
Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases Grant 10,117,850 - Griffioen , et al. November 6, 2	2018-11-06
Indole Amide Derivatives And Related Compounds For Use In The Treatment Of Neurodegenerative Diseases App 20160324828 - Griffioen; Gerard ; et al.	2016-11-10
Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases Grant 9,434,722 - Griffioen , et al. September 6, 2	2016-09-06
3-carboxy Substituted Coumarin Derivatives With A Potential Utility For The Treatment Of Cancer Diseases App 20160115146 - Draoui; Nihid ; et al.	2016-04-28
Compounds for the treatment of neurodegenerative diseases Grant 9,284,271 - Griffioen , et al. March 15, 2	2016-03-15
Compounds for the treatment of neurodegenerative diseases Grant 9,266,832 - Griffioen , et al. February 23, 2	2016-02-23
Indole Amide Derivatives And Related Compounds For Use In The Treatment Of Neurodegenerative Diseases App 20140066457 - Griffioen; Gerard ; et al.	2014-03-06
Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases Grant 8,618,138 - Griffioen , et al. December 31, 2	2013-12-31
Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases Grant 08618138 -	2013-12-31
Novel Compounds For The Treatment Of Neurodegenerative Diseases App 20130289033 - Griffioen; Gerard ; et al.	2013-10-31
New Compounds For The Treatment Of Neurodegenerative Diseases App 20130274260 - Griffioen; Gerard ; et al.	2013-10-17
Indole Amide Derivatives And Related Compounds For Use In The Treatment Of Neurodegenerative Diseases App 20120083475 - Griffioen; Gerard ; et al.	2012-04-05
HIV inhibiting 1,2,4-triazin-6-one derivatives Grant 7,923,554 - Hoornaert , et al. April 12, 2	2011-04-12
HIV inhibiting 1,2,4-triazines Grant 7,585,861 - Lewi , et al. September 8, 2	2009-09-08
Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives App 20090012092 - Hoornaert; Georges Joseph Cornelius ; et al.	2009-01-08
Hiv inhibiting 1,2,4-triazines App 20070037811 - Lewi; Paulus Joannes ; et al.	2007-02-15
HIV inhibiting pyrazinone derivatives Grant 7,105,522 - Janssen , et al. September 12, 2	2006-09-12
Hiv inhibiting pyrazinone derivatives App 20040102456 - Janssen, Paul Adriaan Jan ; et al.	2004-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.